BGOG-ov-1

A Phase II international multicenter randomized study testing the effect on survival of prolonging platinum-free interval in patients with ovarian cancer recurring between 6 and 12 months after previous platinum based chemotherapy.

 

Study sites

  • AZ Damiaan Oostende
  • AZ Groeninge, Kortrijk
  • AZ Klina, Brasschaat
  • AZ Nikolaas, St-Niklaas
  • AZ St. Maarten Duffel, Duffel
  • Clinique Ste-Elisabeth, Namur
  • Clinique St. Joseph, Liège
  • CHR Citadelle, Liège
  • CHU Tivoli, La Louvière
  • Imeldaziekenhuis Bonheiden
  • UZ Leuven, Leuven

 

 

Professional Area

Unlock